Preliminary data from four studies of double PI regimen using once daily Fortovase plus “mini dose” ritonavir
17 May 2001. Related: Antiretrovirals, Treatment strategies.
Treatment strategies
Interleukin-2 improves CD4+ cell counts in patients with poor immune response to HAART
17 April 2001. Related: Treatment strategies.
Use of cytokines in HIV: colony-stimulating factors, erythropoietin, and interleukin-2
17 April 2001. Related: Treatment strategies.
Structured treatment interruptions
17 December 2000. Related: Conference reports, Treatment strategies.
Study shows immune system can control HIV: early antiviral treatment primes the immune system to suppress viral levels without drugs
17 October 2000. Related: Treatment strategies, Basic science and immunology.
Human IL-12 may augment HIV-specific immunity in HIV-positive patients
17 October 2000. Related: Treatment strategies.
Structured treatment interruptions and treatment intensification
16 September 2000. Related: Treatment strategies.
New developments in affordable antiretroviral therapy: intermittent treatment
16 August 2000. Related: Conference reports, Treatment strategies.
Once-daily protease-based regimens
16 August 2000. Related: Conference reports, Antiretrovirals, Treatment strategies.
What is the significance of blips in viral load?
16 July 2000. Related: Conference reports, Treatment strategies.
Phase III study of GM-CSF in advanced HIV disease
15 June 2000. Related: Treatment strategies.
GM-CSF beneficial for patients with advanced HIV disease
15 May 2000. Related: Treatment strategies.
French National Drug Agency re-commends use of IL-2 if HAART does not lead to an increase in CD4 count to greater than 200 cells/mm3
14 April 2000. Related: Treatment strategies.